Bright Minds Biosciences (DRUG) Equity Income (2020 - 2024)
Bright Minds Biosciences (DRUG) posted Equity Income of $35513.3 for Q4 2024, down 93.74% on a QoQ basis from $566973.6 in Q3 2024, and up 102.87% year-over-year from $17505.4 in Q1 2024.
Bright Minds Biosciences (DRUG) Equity Income (2020 - 2024) Analysis & Trends
Bright Minds Biosciences' Equity Income history runs 5 years deep, the most recent figure standing at $35513.3 for Q4 2024.
- Quarterly Equity Income rose 102.87% year-over-year to $35513.3 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $344500.6 (up 107.02% YoY) and the FY2024 annual result came in at $566973.6, up 153.04% from the prior year.
- Equity Income was $35513.3 for Q4 2024 at Bright Minds Biosciences, down from $566973.6 in the prior quarter.
- Across five years, Equity Income topped out at $2.3 million in Q3 2022 and bottomed at -$2.9 million in Q2 2021.
- A 5-year average of -$345865.4 and a median of -$195282.2 in 2024 frame the typical range for Equity Income.
- Annual changes were most pronounced in 2023 — Equity Income slumped 147.08% — and 2024, when it jumped 153.04%.
- Bright Minds Biosciences' Equity Income stood at $511670.0 in 2020, then tumbled by 661.8% to -$2.9 million in 2021, then surged by 40.15% to -$1.7 million in 2022, then advanced by 28.09% to -$1.2 million in 2023, then soared by 102.87% to $35513.3 in 2024.
- Business Quant data shows DRUG's Equity Income at $35513.3 in Q4 2024, $566973.6 in Q3 2024, and $168091.4 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 35,513.28 |
| Sep 30, 2024 | 566,973.56 |
| Jun 30, 2024 | 168,091.41 |
| Mar 31, 2024 | -426,077.62 |
| Dec 31, 2023 | -1.24 Mn |
| Sep 30, 2023 | -1.07 Mn |
| Jun 30, 2023 | -1.09 Mn |
| Mar 31, 2023 | -1.52 Mn |
| Dec 31, 2022 | -1.72 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2021 | -2.87 Mn |
| Mar 31, 2021 | 1.25 Mn |
| Dec 31, 2020 | 511,669.95 |
| Sep 30, 2020 | 283,973.82 |